Skip to main content

Table 1 The clinical characteristics relevance analysis of miR-325 and HMGB1 in patients with HCC

From: RETRACTED ARTICLE: The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1

Characteristics All Patients miR-325 low Expression (≤ Mediana) miR-325 high Expression (> Mediana) p value HMGB1 low Expression (< Medianb) HMGB1 high Expression (≥ Medianb) p value
NO. 99 51 48   49 50  
Age(years)     0.832    0.565
<60 43 21 22   23 20  
≥60 56 28 28   26 30  
Gender     0.713    0.442
Male 46 24 22   25 21  
Female 53 26 27   24 29  
Histology     0.523    0.718
AC 45 23 22   21 24  
SCC 54 28 26   27 27  
Tumor size     0.003*    0.001*
T1/T2 46 17 29   35 11  
T3/T4 53 37 16   18 35  
TNM stage     0.001*    0.000*
I-II 48 10 38   36 12  
III-IV 51 35 16   10 41  
Metastasis     0.000*    0.000*
Yes 33 27 6   4 29  
No 66 23 43   45 21  
  1. amedian = 0.5115
  2. bmedian = 3.0011
  3. *denotes p value < 0.05
  4. AC: adenocarcinoma; SCC: squamous cell carcinoma; HCC: hepatocellular carcinoma